Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device: a prospective open-label Scandinavian noninterventional study (the ScanSmart study)

Elena Didenko Pedersen,1,2 Egon Stenager,3,4 JL Vadgaard,5 MB Jensen,6 R Schmid,7 N Meland,8 G Magnussen,9 Jette L Frederiksen10,11 1Akershus University Hospital, Department of Neurology, Loerenskog, Norway; 2Sandvika Nevrosenter, Sandvika, Norway; 3MS Clinic of Southern Jutland, Department of Neur...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Patient Preference and Adherence
المؤلفون الرئيسيون: Pedersen ED, Stenager E, Vadgaard JL, Jensen MB, Schmid R, Meland N, Magnussen G, Frederiksen JL
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Dove Medical Press 2018-04-01
الموضوعات:
Adherence
multiple sclerosis
relapsing remitting MS
subcutaneous interferon beta-1a
RebiSmart®
trial
الوصول للمادة أونلاين:https://www.dovepress.com/adherence-to-subcutaneous-interferon-beta-1a-treatment-using-an-electr-peer-reviewed-article-PPA

الانترنت

https://www.dovepress.com/adherence-to-subcutaneous-interferon-beta-1a-treatment-using-an-electr-peer-reviewed-article-PPA

مواد مشابهة